Viavi price target raised to $17 from $16 at Northland

Northland raised the firm’s price target on Viavi (VIAV) to $17 from $16 and keeps an Outperform rating on the shares. The firm remains “big fans” of the Spirent deal, which it sees increasing the scale of the company’s already significant AI Optical exposure, and views the company’s announcement yesterday of the deal closing as “a positive catalyst for the shares,” the analyst tells investors.